-DOCSTART- -X- O
Acute -X- _ B-Patient
respiratory -X- _ I-Patient
distress -X- _ I-Patient
syndrome -X- _ I-Patient
( -X- _ I-Patient
ARDS -X- _ I-Patient
) -X- _ I-Patient
is -X- _ O
defined -X- _ O
by -X- _ O
the -X- _ O
association -X- _ O
of -X- _ O
bilateral -X- _ O
infiltrates -X- _ O
and -X- _ O
hypoxaemia -X- _ O
following -X- _ O
an -X- _ O
initial -X- _ O
insult. -X- _ O
Although -X- _ O
a -X- _ O
new -X- _ O
definition -X- _ O
has -X- _ O
been -X- _ O
recently -X- _ O
proposed -X- _ O
( -X- _ O
Berlin -X- _ O
definition -X- _ O
) -X- _ O
, -X- _ O
there -X- _ O
are -X- _ O
various -X- _ O
forms -X- _ O
of -X- _ O
ARDS -X- _ O
with -X- _ O
potential -X- _ O
differences -X- _ O
regarding -X- _ O
their -X- _ O
management -X- _ O
( -X- _ O
ventilator -X- _ O
settings -X- _ O
, -X- _ O
prone -X- _ O
positioning -X- _ O
use -X- _ O
, -X- _ O
corticosteroids -X- _ O
) -X- _ O
. -X- _ O
ARDS -X- _ O
can -X- _ O
be -X- _ O
caused -X- _ O
by -X- _ O
various -X- _ O
aetiologies -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
adequate -X- _ O
treatment -X- _ O
of -X- _ O
the -X- _ O
responsible -X- _ O
cause -X- _ O
is -X- _ O
crucial -X- _ O
to -X- _ O
improve -X- _ O
the -X- _ O
outcome. -X- _ O
It -X- _ O
is -X- _ O
of -X- _ O
paramount -X- _ O
importance -X- _ O
to -X- _ O
characterize -X- _ O
the -X- _ O
mechanisms -X- _ O
causing -X- _ O
lung -X- _ O
injury -X- _ O
to -X- _ O
optimize -X- _ O
both -X- _ O
the -X- _ O
aetiological -X- _ O
treatment -X- _ O
and -X- _ O
the -X- _ O
symptomatic -X- _ O
treatment. -X- _ O
If -X- _ O
there -X- _ O
is -X- _ O
no -X- _ O
obvious -X- _ O
cause -X- _ O
of -X- _ O
ARDS -X- _ O
or -X- _ O
if -X- _ O
a -X- _ O
direct -X- _ O
lung -X- _ O
injury -X- _ O
is -X- _ O
suspected -X- _ O
, -X- _ O
bronchoalveolar -X- _ B-Intervention
lavage -X- _ I-Intervention
( -X- _ I-Intervention
BAL -X- _ I-Intervention
) -X- _ I-Intervention
should -X- _ O
be -X- _ O
strongly -X- _ O
considered -X- _ O
to -X- _ O
identify -X- _ B-Outcome
microorganisms -X- _ I-Outcome
responsible -X- _ I-Outcome
for -X- _ I-Outcome
pneumonia. -X- _ I-Outcome
Blood -X- _ B-Intervention
samples -X- _ I-Intervention
can -X- _ O
also -X- _ O
help -X- _ B-Outcome
to -X- _ I-Outcome
identify -X- _ I-Outcome
microorganisms -X- _ I-Outcome
and -X- _ I-Outcome
to -X- _ I-Outcome
evaluate -X- _ I-Outcome
biomarkers -X- _ I-Outcome
of -X- _ I-Outcome
infection. -X- _ I-Outcome
If -X- _ O
there -X- _ O
is -X- _ O
no -X- _ O
infectious -X- _ O
cause -X- _ O
of -X- _ O
ARDS -X- _ O
or -X- _ O
no -X- _ O
other -X- _ O
apparent -X- _ O
aetiology -X- _ O
is -X- _ O
found -X- _ O
, -X- _ O
second-line -X- _ B-Intervention
examinations -X- _ I-Intervention
should -X- _ O
include -X- _ O
markers -X- _ O
of -X- _ O
immunologic -X- _ O
diseases. -X- _ O
In -X- _ O
selected -X- _ O
cases -X- _ O
, -X- _ O
open -X- _ B-Intervention
lung -X- _ I-Intervention
biopsy -X- _ I-Intervention
remains -X- _ O
useful -X- _ O
to -X- _ O
identify -X- _ O
the -X- _ O
cause -X- _ O
of -X- _ O
ARDS -X- _ O
when -X- _ O
all -X- _ O
other -X- _ O
examinations -X- _ O
remain -X- _ O
inconclusive. -X- _ O
CT -X- _ B-Intervention
scan -X- _ I-Intervention
is -X- _ O
fundamental -X- _ O
when -X- _ O
there -X- _ B-Outcome
is -X- _ I-Outcome
a -X- _ I-Outcome
suspicion -X- _ I-Outcome
of -X- _ I-Outcome
intra-abdominal -X- _ I-Outcome
sepsis -X- _ I-Outcome
and -X- _ I-Outcome
in -X- _ I-Outcome
some -X- _ I-Outcome
cases -X- _ I-Outcome
of -X- _ I-Outcome
pneumonia. -X- _ I-Outcome
Ultrasonography -X- _ B-Intervention
is -X- _ O
important -X- _ O
not -X- _ O
only -X- _ O
in -X- _ O
evaluating -X- _ O
biventricular -X- _ O
function -X- _ O
but -X- _ O
also -X- _ O
in -X- _ O
identifying -X- _ B-Outcome
pleural -X- _ I-Outcome
effusions -X- _ I-Outcome
and -X- _ I-Outcome
pneumothorax. -X- _ I-Outcome
The -X- _ O
definition -X- _ O
of -X- _ O
ARDS -X- _ O
remains -X- _ O
clinical -X- _ O
and -X- _ O
the -X- _ O
main -X- _ O
objective -X- _ O
of -X- _ O
the -X- _ O
diagnostic -X- _ O
workup -X- _ O
should -X- _ O
be -X- _ O
to -X- _ O
be -X- _ O
focused -X- _ O
on -X- _ O
identification -X- _ O
of -X- _ O
its -X- _ O
aetiology -X- _ O
, -X- _ O
especially -X- _ O
a -X- _ O
treatable -X- _ O
infection. -X- _ O
ELECTRONIC -X- _ O
SUPPLEMENTARY -X- _ O
MATERIAL -X- _ O
: -X- _ O
The -X- _ O
online -X- _ O
version -X- _ O
of -X- _ O
this -X- _ O
article -X- _ O
( -X- _ O
doi:10.1007 -X- _ O
/ -X- _ O
s00134-016-4324-5 -X- _ O
) -X- _ O
contains -X- _ O
supplementary -X- _ O
material -X- _ O
, -X- _ O
which -X- _ O
is -X- _ O
available -X- _ O
to -X- _ O
authorized -X- _ O
users -X- _ O
. -X- _ O

